China Innovation Investment Limited (HK:1217) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
China Innovation Investment Limited has issued a declaration urging Elife Holdings Limited to consider the potential repercussions of a breach of contract following a requisition by minority shareholders to alter Elife’s board. The removal of certain directors could impact China Innovation’s management rights over Elife and undermine their investment intentions, leading to possible detriments to both companies’ interests. The company requests careful consideration from Elife’s board and shareholders to address this matter prudently.
For further insights into HK:1217 stock, check out TipRanks’ Stock Analysis page.